AMBROXOL EG LABO CONSEIL 0.6 %, oral solution bottle, 150 ml
Active ingredients: Ambroxol hydrochloride
Commercialized according to BDPM
Oral solutionbottle, 150 mlorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- AMBROXOL EG LABO CONSEIL 0,6 %, solution buvable
- Pharmaceutical form
- solution buvable
- Route of administration
- orale
- Presentation description
- 1 flacon(s) en verre brun de 150 ml avec cuillère-mesure polystyrène
- Marketing authorisation holder
- EG LABO - LABORATOIRES EUROGENERICS
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 19 Aug 2003
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61494243CIP73619510CIP133400936195103Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE D'AMBROXOLsolution | 0,6 g · 100 ml de solution buvable | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.